Trademark: 90420110
Word
SANGAMO THERAPEUTICS
Status
Pending
Status Code
733
Status Date
Thursday, February 22, 2024
Serial Number
90420110
Mark Type
3000
Filing Date
Monday, December 28, 2020
Published for Opposition
Tuesday, December 28, 2021

Trademark Owner History
Sangamo Therapeutics, Inc. - Owner At Publication

Classifications
5 Biochemicals, biologics, and pharmaceutical preparations, namely, reagents in the nature of engineered proteins for gene regulation, genome engineering, gene modulation, transcriptional regulation, transcriptional modulation, gene modification, and gene correction, all for clinical medical use and medical use in the fields of human and animal therapeutics, diagnostics, bioinformatics, genetic diseases, gene therapy, and cell therapy; Reagents, namely, engineered nucleic acids, viral vectors, non-viral vectors, gene therapy vectors, gene editing vectors, genetically modified cells, engineered proteins for multiplexed gene editing, mRNA and recombinant adeno-associated virus (AAV) vectors for delivery of therapeutic DNA or mRNA sequences to cells, antibody preparations, CAR T-cell preparations, T-cell preparations, B-cell preparations, Treg preparations, and NK cell preparations, all for clinical medical use and medical use
1 Biochemicals and biologics, namely, engineered proteins in raw material form for gene regulation, genome engineering, gene modulation, transcriptional regulation, transcriptional modulation, gene modification, and gene correction, all for use in scientific research, medical pharmaceutical research, scientific agricultural biotechnology research, medical diagnostics research, industrial scientific biotechnology research and all for clinical medical laboratory use and medical laboratory use in the fields of human and animal therapeutics, diagnostics, bioinformatics, genetic diseases, gene therapy, and cell therapy; engineered proteins in raw material form for use in scientific research and analysis relating to genetic diseases, gene therapy, cell therapy, genome editing, and genome regulation; biochemicals and biologics, namely, reagents in the nature of engineered nucleic acids for laboratory use, viral vectors, non-viral vectors, gene therapy vectors, gene editing vectors, genetically modified cells, engineered proteins in raw material form for multiplexed gene editing, mRNA and recombinant adeno-associated virus (AAV) vectors for delivery of therapeutic DNA or mRNA sequences to cells, antibody preparations, CAR T-cell preparations, T-cell preparations, B-cell preparations, Treg preparations, and NK cell preparations, all for use in scientific research, analysis and diagnostics and all for medical clinical laboratory use and medical laboratory use
45 Licensing of intellectual property rights
42 Medical and scientific research; technical scientific research and medical research consulting in the fields of bioinformatics and gene regulation, gene modification, and gene correction; product research and development of engineered proteins and nucleic acids for others; product design of genetic research tools and systems for others; custom product development of engineered proteins for use in gene editing
The mark consists of the wording "SANGAMO" in a stylized font with the letter "O" in "SANGAMO" comprised of two concentric circles with the outer circle being broken by two diagonal lines and the word "THERAPEUTICS" in a stylized font is centered below the letters "AMO" in the wording "SANGAMO".
"THERAPEUTICS"

Trademark Events
Feb 23, 2024
Notice Of Approval Of Extension Request E-Mailed
Feb 22, 2024
Sou Extension 4 Granted
Feb 22, 2024
Sou Extension 4 Filed
Feb 22, 2024
Sou Teas Extension Received
Aug 22, 2023
Notice Of Approval Of Extension Request E-Mailed
Aug 18, 2023
Sou Extension 3 Granted
Aug 18, 2023
Sou Extension 3 Filed
Aug 18, 2023
Sou Teas Extension Received
Feb 22, 2023
Notice Of Approval Of Extension Request E-Mailed
Feb 20, 2023
Sou Extension 2 Granted
Feb 20, 2023
Sou Extension 2 Filed
Feb 20, 2023
Sou Teas Extension Received
Feb 15, 2023
Applicant/Correspondence Changes (Non-Responsive) Entered
Feb 15, 2023
Teas Change Of Correspondence Received
Feb 15, 2023
Teas Change Of Owner Address Received
Sep 22, 2022
Notice Of Approval Of Extension Request E-Mailed
Sep 21, 2022
Sou Extension 1 Granted
Aug 22, 2022
Sou Extension 1 Filed
Sep 19, 2022
Response To Itu Office Action Entered
Sep 19, 2022
Teas Response To Office Action Received
Sep 15, 2022
Itu Office Action Issued For Extension Request
Sep 15, 2022
Case Assigned To Intent To Use Paralegal
Aug 22, 2022
Fax Received
Aug 22, 2022
Applicant/Correspondence Changes (Non-Responsive) Entered
Aug 22, 2022
Teas Change Of Correspondence Received
Aug 22, 2022
Teas Change Of Owner Address Received
Feb 22, 2022
Noa E-Mailed - Sou Required From Applicant
Dec 28, 2021
Official Gazette Publication Confirmation E-Mailed
Dec 28, 2021
Published For Opposition
Dec 8, 2021
Notification Of Notice Of Publication E-Mailed
Nov 23, 2021
Approved For Pub - Principal Register
Nov 15, 2021
Teas/Email Correspondence Entered
Nov 15, 2021
Correspondence Received In Law Office
Nov 15, 2021
Teas Response To Office Action Received
Jun 30, 2021
Notification Of Non-Final Action E-Mailed
Jun 30, 2021
Non-Final Action E-Mailed
Jun 30, 2021
Non-Final Action Written
Jun 24, 2021
Assigned To Examiner
Mar 18, 2021
Notice Of Design Search Code E-Mailed
Mar 17, 2021
New Application Office Supplied Data Entered
Dec 31, 2020
New Application Entered

Trademark Alertz updated from USPTO on 2030-01-24